Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126378325 | 12637832 | 5 | F | 2010 | 20160901 | 20160809 | 20160902 | EXP | US-PFIZER INC-2016377934 | PFIZER | 54.00 | YR | F | Y | 100.00000 | KG | 20160902 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126378325 | 12637832 | 1 | PS | DEPO-PROVERA | MEDROXYPROGESTERONE ACETATE | 1 | UNK, SINGLE | Y | 12541 | SUSPENSION FOR INJECTION | |||||||||
| 126378325 | 12637832 | 2 | SS | DEPO-PROVERA | MEDROXYPROGESTERONE ACETATE | 1 | Intramuscular | 1 ML, EVERY 3 MONTHS (150 MG/ML SHOT) | U | X02351 | 20246 | 1 | ML | SUSPENSION FOR INJECTION | |||||
| 126378325 | 12637832 | 3 | SS | MEDROXYPROGESTERONE ACETATE. | MEDROXYPROGESTERONE ACETATE | 1 | Intramuscular | 150 MG, UNK | U | X02351 | 20246 | 150 | MG | SUSPENSION FOR INJECTION | |||||
| 126378325 | 12637832 | 4 | C | ALBUTEROL. | ALBUTEROL | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126378325 | 12637832 | 1 | Vaginal haemorrhage |
| 126378325 | 12637832 | 2 | Menstrual cycle management |
| 126378325 | 12637832 | 3 | Vaginal haemorrhage |
| 126378325 | 12637832 | 4 | Asthma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126378325 | 12637832 | OT |
| 126378325 | 12637832 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126378325 | 12637832 | Abdominal discomfort | |
| 126378325 | 12637832 | Abdominal pain | |
| 126378325 | 12637832 | Activities of daily living impaired | |
| 126378325 | 12637832 | Drug ineffective for unapproved indication | |
| 126378325 | 12637832 | Dysmenorrhoea | |
| 126378325 | 12637832 | Gait disturbance | |
| 126378325 | 12637832 | Menorrhagia | |
| 126378325 | 12637832 | Pain | |
| 126378325 | 12637832 | Pelvic pain | |
| 126378325 | 12637832 | Rash pruritic | |
| 126378325 | 12637832 | Vulvovaginal pain | |
| 126378325 | 12637832 | Vulvovaginal pruritus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126378325 | 12637832 | 1 | 2010 | 0 | ||
| 126378325 | 12637832 | 2 | 20101115 | 20110215 | 0 | |
| 126378325 | 12637832 | 3 | 20101115 | 0 |